- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
ALZ
STO
Week ended 07 Aug 2026
Weekly Investor Report
Alzinova AB (publ) · Healthcare · Biotechnology
Latest close
1.06 SEK
-8.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 67.6% above the Trend Line and sits at 35.9% of its 52-week range. The latest completed week returned -8.3%, after a 52.0% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
40
out of 100
Latest Close
1.06 SEK
7 Aug 2026
1W Return
-8.3%
latest completed week
4W Return
52.0%
short-term follow-through
12W Return
133.6%
quarterly tape
Trend Breadth
1.9%
1 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 42.39% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-8.3%
Latest completed week; four-week move 52.0%.
Indicator stack
5/81
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.39%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 67.6% above the Trend Line and sits at 35.9% of its 52-week range. The latest completed week returned -8.3%, after a 52.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1812-week average 0.06
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 52.0% over four weeks, 133.6% over 12 weeks, and -20.6% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year1
Trend breadth1.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.39Latest activity-pressure read.
Pressure change79.4%Four-week change in activity pressure.
Leadership-1.12Latest relative-leadership reading.
RS change97.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-53.3%Distance below the 52-week high.
13-week volatility16.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+57.3%Week of 13 Mar.
Worst week-34.5%Week of 20 Mar.
Latest week-8.3%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains4
Flat weeks0
Modest losses5
Sharp losses10
Recent vol16.4%13-week weekly-return volatility.
Base vol18.7%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew16.8% / -10.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank- / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Biotechnology
4-week rank2 / 58
Group average3.5%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis36/100Latest 12-week confirmation: trend 1/12, activity pressure 12/12, relative leadership 1/12.
Activity pressure 0.18; No reversal markers Next-Week ExpectancyNegative 42.39%Next-week expectancy is negative with a 42.39% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Alzinova gears up for phase II with secured funding Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.06 SEK | -8.3% | 0.63 SEK | 2.02 SEK | 1.39 | -1.12 | 15.7M | On |
| 31 Jul 2026 | 1.16 SEK | 38.1% | 0.63 SEK | 2.04 SEK | 1.47 | 8.73 | 27.7M | Off |
| 24 Jul 2026 | 0.84 SEK | 25.6% | 0.62 SEK | 2.05 SEK | 1.28 | -21.18 | 14.7M | Off |
| 17 Jul 2026 | 0.67 SEK | -4.4% | 0.61 SEK | 2.07 SEK | 1.17 | -37.67 | 17.0M | Off |
| 10 Jul 2026 | 0.70 SEK | 41.4% | 0.64 SEK | 2.09 SEK | 0.78 | -37.35 | 211.1M | Off |
| 3 Jul 2026 | 0.49 SEK | -9.2% | 0.67 SEK | 2.11 SEK | 0.42 | -57.66 | 1.1M | Off |
| 26 Jun 2026 | 0.55 SEK | 13.7% | 0.72 SEK | 2.12 SEK | 0.24 | -53.39 | 1.2M | Off |
| 19 Jun 2026 | 0.48 SEK | -1.3% | 0.76 SEK | 2.14 SEK | 0.08 | -60.27 | 1.8M | Off |
| 12 Jun 2026 | 0.49 SEK | 9.0% | 0.79 SEK | 2.16 SEK | 0.26 | -60.07 | 665.7K | Off |
| 5 Jun 2026 | 0.45 SEK | 3.6% | 0.82 SEK | 2.17 SEK | 0.23 | -64.39 | 389.4K | Off |
| 29 May 2026 | 0.43 SEK | -9.0% | 0.86 SEK | 2.19 SEK | 0.20 | -66.64 | 6.3M | Off |
| 22 May 2026 | 0.47 SEK | 3.8% | 0.89 SEK | 2.20 SEK | 0.04 | -64.34 | 7.7M | Off |
| 15 May 2026 | 0.46 SEK | 13.6% | 0.92 SEK | 2.22 SEK | -0.01 | -65.33 | 4.8M | Off |
| 8 May 2026 | 0.40 SEK | -9.4% | 0.95 SEK | 2.24 SEK | -0.04 | -70.61 | 3.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.